Sympathetic neurotransmitters and tumor angiogenesislink between stress and cancer progression

Journal of Oncology

Volumn , Issue , 2010, Pages

  Kitlinska, Joanna ^a   Tilan, Jason ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROTRANSMITTER; NORADRENALIN; VASCULOTROPIN;

ADRENERGIC TRANSMISSION; ANTIANGIOGENIC ACTIVITY; CANCER GROWTH; CANCER INHIBITION; CARDIOVASCULAR DISEASE; CATECHOLAMINE RELEASE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC STRESS; DRUG MECHANISM; ENDOTHELIUM CELL; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 77953526545     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/539706     Document Type: Review

References (60)

1. Chrousos G. P., Gold P. W., The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis Journal of the American Medical Association 1992 267 9 1244 1252
2. Seeman T. E., Singer B. H., Rowe J. W., Horwitz R. I., McEwen B. S., Price of adaptationallostatic load and its health consequences: MacArthur studies of successful aging Archives of Internal Medicine 1997 157 19 2259 2268
3. McEwen B. S., Stellar E., Stress and the individual. Mechanisms leading to disease Archives of Internal Medicine 1993 153 18 2093 2101
4. Antoni M. H., Lutgendorf S. K., Cole S. W., The influence of bio-behavioural factors on tumour biology: pathways and mechanisms Nature Reviews Cancer 2006 6 3 240 248
5. Thaker P. H., Han L. Y., Kamat A. A., Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma Nature Medicine 2006 12 8 939 944
6. Lee J.-W., Shahzad M. M. K., Lin Y. G., Surgical stress promotes tumor growth in ovarian carcinoma Clinical Cancer Research 2009 15 8 2695 2702
7. Godbout J. P., Glaser R., Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer Journal of Neuroimmune Pharmacology 2006 1 4 421 427
8. Dhabhar F. S., Saul A. N., Daugherty C., Holmes T. H., Bouley D. M., Oberyszyn T. M., Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma Brain, Behavior, and Immunity 2010 24 1 127 137
9. Dhabhar F. S., Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology NeuroImmunoModulation 2009 16 5 300 317
10. Kitlinska J., Abe K., Kuo L., Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors Cancer Research 2005 65 5 1719 1728
11. Palm D., Lang K., Niggemann B., The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by -blockers International Journal of Cancer 2006 118 11 2744 2749
12. Sood A. K., Bhatty R., Kamat A. A., Stress hormone-mediated invasion of ovarian cancer cells Clinical Cancer Research 2006 12 2 369 375
13. Carie A. E., Sebti S. M., A chemical biology approach identifies a -2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway Oncogene 2007 26 26 3777 3788
14. Sarkar C., Chakroborty D., Chowdhury U. R., Dasgupta P. S., Basu S., Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models Clinical Cancer Research 2008 14 8 2502 2510
15. Chakroborty D., Sarkar C., Basu B., Dasgupta P. S., Basu S., Catecholamines regulate tumor angiogenesis Cancer Research 2009 69 9 3727 3730
16. Yang E. V., Kim S.-J., Donovan E. L., Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression Brain, Behavior, and Immunity 2009 23 2 267 275
17. Goldstein D. S., Catecholamines and stress Endocrine Regulations 2003 37 2 69 80
18. Ben-Eliyahu S., Yirmiya R., Liebeskind J. C., Taylor A. N., Gale R. P., Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system Brain, Behavior, and Immunity 1991 5 2 193 205
19. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., Ben-Eliyahu S., Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a -adrenergic antagonist and a prostaglandin synthesis inhibitor Brain, Behavior, and Immunity 2005 19 2 114 126
20. Yang Z. R., Chou K.-C., Bio-support vector machines for computational proteomics Bioinformatics 2004 20 5 735 741
21. Yang E. V., Sood A. K., Chen M., Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells Cancer Research 2006 66 21 10357 10364
22. Nilsson M. B., Armaiz-Pena G., Takahashi R., Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism The Journal of Biological Chemistry 2007 282 41 29919 29926
23. Wong H. P. S., Yu L., Lam E. K. Y., Tai E. K. K., Wu W. K. K., Cho C.-H., Nicotine promotes colon tumor growth and angiogenesis through -adrenergic activation Toxicological Sciences 2007 97 2 279 287
24. Pollard J. W., Tumour-educated macrophages promote tumour progression and metastasis Nature Reviews Cancer 2004 4 1 71 78
25. Lutgendorf S. K., Lamkin D. M., Jennings N. B., Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma Clinical Cancer Research 2008 14 21 6839 6846
26. Vinci M. C., Bellik L., Filippi S., Trophic effects induced by 1D -adrenoceptors on endothelial cells are potentiated by hypoxia American Journal of Physiology 2007 293 4 H2140 H2147
27. Borovsky V., Herman M., Dunphy G., CO 2 asphyxia increases plasma norepinephrine in rats via sympathetic nerves American Journal of Physiology 1998 274 1, part 2 R19 R22
28. Perron L., Bairati I., Harel F., Meyer F., Antihypertensive drug use and the risk of prostate cancer (Canada) Cancer Causes and Control 2004 15 6 535 541
29. Rodriguez C., Jacobs E. J., Deka A., Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Causes and Control 2009 20 5 671 679
30. Pifl C., Zezula J., Spittler A., Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter The FASEB Journal 2001 15 9 1607 1609
31. Scarparo A. C., Sumida D. H., Patro M. T. C. C., Avellar M. C. W., Visconti M. A., Castrucci A. M. D. L., Catecholamine effects on human melanoma cells evoked by 1 -adrenoceptors Archives of Dermatological Research 2004 296 3 112 119
32. Drell T. L. IV, Joseph J., Lang K., Niggemann B., Zaenker K. S., Entschladen F., Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells Breast Cancer Research and Treatment 2003 80 1 63 70
33. Meier C. R., Derby L. E., Jick S. S., Jick H., Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer Archives of Internal Medicine 2000 160 3 349 353
34. Li C. I., Malone K. E., Weiss N. S., Boudreau D. M., Cushing-Haugen K. L., Daling J. R., Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 6579 years Cancer 2003 98 7 1504 1513
35. Snider S. R., Kuchel O., Dopamine: an important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension Endocrine Reviews 1983 4 3 291 309
36. Chakroborty D., Sarkar C., Mitra R. B., Banerjee S., Dasgupta P. S., Basu S., Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis Clinical Cancer Research 2004 10 13 4349 4356
37. Asada M., Ebihara S., Numachi Y., Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter International Journal of Cancer 2008 123 3 511 518
38. Basu S., Nagy J. A., Pal S., The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor Nature Medicine 2001 7 5 569 574 (Pubitemid 32448324)
39. Sarkar C., Chakroborty D., Mitra R. B., Banerjee S., Dasgupta P. S., Basu S., Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells American Journal of Physiology 2004 287 4 H1554 H1560
40. Chakroborty D., Chowdhury U. R., Sarkar C., Baral R., Dasgupta P. S., Basu S., Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization Journal of Clinical Investigation 2008 118 4 1380 1389
41. Colmers W. F., Wahlestedt C., The Biology of Neuropeptide Y and Related Peptides 1993 Totowa, NJ, USA Humana Press
42. Zukowska-Grojec Z., Pruszczyk P., Colton C., Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells Peptides 1993 14 2 263 268
43. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Neuropeptide Y a novel angiogenic factor from the sympathetic nerves and endothelium Circulation Research 1998 83 2 187 195
44. Hansel D. E., Eipper B. A., Ronnett G. V., Neuropeptide Y functions as a neuroproliferative factor Nature 2001 410 6831 940 944
45. Pons J., Kitlinska J., Ji H., Bimodal mitogenic action of neuropeptide Y in vascular smooth muscle cells: dimerization of the receptors? Molecular Biology of the Cell 2002 13 supplement, article 80a
46. Lee E. W., Michalkiewicz M., Kitlinska J., Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles Journal of Clinical Investigation 2003 111 12 1853 1862
47. Movafagh S., Hobson J. P., Spiegel S., Kleinman H. K., Zukowska Z., Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors The FASEB Journal 2006 20 11 1924 1926
48. Ekstrand A. J., Cao R., Bjrndahl M., Deletion of neuropeptide Y (NPY)2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6033 6038
49. Lee E. W., Grant D. S., Movafagh S., Zukowska Z., Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice Peptides 2003 24 1 99 106
50. Li L., Lee E. W., Ji H., Zukowska Z., Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 7 1204 1210
51. Koulu M., Movafagh S., Tuohimaa J., Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization Annals of Medicine 2004 36 3 232 240
52. Kuo L. E., Kitlinska J. B., Tilan J. U., Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome Nature Medicine 2007 13 7 803 811
53. Liu C. D., Balasubramaniam A., Saxton R. E., Paiva M., McFadden D. W., Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1 Journal of Surgical Research 1995 58 6 707 712
54. Grise K. R., Rongione A. J., Laird E. C., McFadden D. W., Peptide YY inhibits growth of human breast cancer in vitro and in vivo Journal of Surgical Research 1999 82 2 151 155
55. Heisler T., Towfigh S., Simon N., McFadden D. W., Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells Journal of Surgical Research 2000 91 1 9 14
56. Yu A., Somasundar P., Balsubramaniam A., Rose A. T., Vona-Davis L., McFadden D. W., Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor Journal of Surgical Research 2002 105 1 65 68
57. Zukowska-Grojec Z., Neuropeptide Y. A novel sympathetic stress hormone and more Annals of the New York Academy of Sciences 1995 771 219 233
58. Thorsell A., Michalkiewicz M., Dumont Y., Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression Proceedings of the National Academy of Sciences of the United States of America 2000 97 23 12852 12857
59. Carvajal C. C., Vercauteren F., Dumont Y., Michalkiewicz M., Quirion R., Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning Behavioural Brain Research 2004 153 2 471 480
60. Li L., Jonsson-Rylander A.-C., Abe K., Zukowska Z., Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 10 2075 2080